Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial
Publication in refereed journal


Full Text

Other information
All Author(s) ListGOSS P E, SMITH I E, EJLERTSEN B, YEO Winnie
Journal nameLancet Oncology
Detailed descriptionCollaborators: include Yeo W et al.
Year2013
Month1
Volume Number1
Issue Number14
PublisherLondon : Lancet Pub. Group, c2000-
Place of PublicationUnited Kingdom
Pages88
ISSN1470-2045
eISSN1474-5488
LanguagesEnglish-United Kingdom
Keywordslapatinib; breast cancer

Last updated on 2018-18-01 at 14:21